doi: 10.1161/hc3101.093902
(Circulation. 2001;104:642.)
© 2001 American Heart Association, Inc.
Clinical Investigation and Reports |
Differential Impact on Survival of Electrocardiographic Q-Wave Versus Enzymatic Myocardial Infarction After Percutaneous Intervention
A Device-Specific Analysis of 7147 Patients
From the Cardiovascular Research Foundation (formerly at the Washington Hospital Center), Lenox Hill Heart and Vascular Institute, New York City, NY (G.W.S., R.M., G.D., A.J.L., M.B.L.); and the Washington Hospital Center, Washington, DC (R.K.).
Correspondence to Gregg W. Stone, MD, the Cardiovascular Research Foundation, 55 E 59th St, 6th Floor, New York, NY 10022. E-mail gstone{at}crf.org
Background—— The relative prognostic importance of ECG myocardial infarction (MI) after intervention compared with varying degrees of enzymatic elevation has not been characterized, and the device-specific implications of periprocedural MI are also unknown.
Methods and Results—— Serial creatine phosphokinase (CPK)-MB levels were determined after elective percutaneous intervention of 12 098 lesions in 7147 consecutive patients at a tertiary referral center. Procedural, in-hospital, and follow-up data were collected by independent research nurses, and clinical and ECG events were adjudicated by a separate committee. Stents were implanted in 50.6% of lesions, atheroablation was performed in 54.8%, and PTCA alone was performed in 9.8%. The peak periprocedural CPK-MB level was >3x the upper limit of normal (ULN) in 17.9% of patients, and Q-wave MI developed in 0.6%. By multivariate analysis, the periprocedural development of new Q waves was the most powerful independent determinant of death (2-year mortality rate, 38.3%; hazard ratio, 9.9; P<0.0001). Non–Q-wave MI with CPK-MB >8x ULN was also a strong predictor of death (2-year mortality rate, 16.3%; hazard ratio, 2.2; P<0.0001); survival was unaffected by lesser degrees of CPK-MB elevation. Though CPK-MB elevation was more common after atheroablation and stenting than PTCA, the rates of Q-wave MI and survival were device-independent.
Conclusions—— Myonecrosis after percutaneous intervention is common in a high-risk referral population dominated by atheroablation and stent use. Large periprocedural infarctions (signified by new Q waves and CPK-MB >8xULN) are powerful determinants of death, whereas lesser degrees of CPK-MB release and specific device use do not adversely affect survival.
Key Words: angioplasty • stents • complications
Related Article:
Circulation 2001 104: 627-629.
This article has been cited by other articles:
 |
|
 |
|
  J. M. Wilson and J. T. Willerson Myocardial Revascularization with Percutaneous Devices Card. Surg. Adult, January 1, 2008; 3(2008): 573 - 598. [Full Text]
|
|
|
|
 |
|
 G. W. Stone, J. H. Ware, M. E. Bertrand, A. M. Lincoff, J. W. Moses, E. M. Ohman, H. D. White, F. Feit, A. Colombo, B. T. McLaurin, et al. Antithrombotic Strategies in Patients With Acute Coronary Syndromes Undergoing Early Invasive Management: One-Year Results From the ACUITY Trial JAMA, December 5, 2007; 298(21): 2497 - 2506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Kereiakes, P. S. Teirstein, I. J. Sarembock, D. R. Holmes Jr, M. W. Krucoff, W. W. O'Neill, R. Waksman, D. O. Williams, J. J. Popma, M. Buchbinder, et al. The Truth and Consequences of the COURAGE Trial J. Am. Coll. Cardiol., October 16, 2007; 50(16): 1598 - 1603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. W. Stone, S. G. Ellis, A. Colombo, K. D. Dawkins, E. Grube, D. E. Cutlip, M. Friedman, D. S. Baim, and J. Koglin Offsetting Impact of Thrombosis and Restenosis on the Occurrence of Death and Myocardial Infarction After Paclitaxel-Eluting and Bare Metal Stent Implantation Circulation, June 5, 2007; 115(22): 2842 - 2847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Cutlip, S. Windecker, R. Mehran, A. Boam, D. J. Cohen, G.-A. van Es, P. Gabriel Steg, M.-a. Morel, L. Mauri, P. Vranckx, et al. Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions Circulation, May 1, 2007; 115(17): 2344 - 2351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Prasad, M. Singh, A. Lerman, R. J. Lennon, D. R. Holmes Jr, and C. S. Rihal Isolated Elevation in Troponin T After Percutaneous Coronary Intervention Is Associated With Higher Long-Term Mortality J. Am. Coll. Cardiol., November 7, 2006; 48(9): 1765 - 1770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Levitsky Protecting the Myocardial Cell During Coronary Revascularization Circulation, July 4, 2006; 114(1_suppl): I-339 - I-343. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D P Chew, D L Bhatt, A M Lincoff, K Wolski, and E J Topol Clinical end point definitions after percutaneous coronary intervention and their relationship to late mortality: an assessment by attributable risk Heart, July 1, 2006; 92(7): 945 - 950. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Colombo and G. Stankovic The Value of Selectivity J. Am. Coll. Cardiol., February 21, 2006; 47(4): 719 - 720. [Full Text] [PDF]
|
|
|
|
|
|
S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr, A. K. Jacobs, M. J. Kern, S. B. King III, D. A. Morrison, W. W. O'Neill, H. V. Schaff, P. L. Whitlow, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) J. Am. Coll. Cardiol., January 3, 2006; 47(1): 216 - 235. [Full Text] [PDF]
|
|
|
|
|
|
S. C. Smith Jr, T. E. Feldman, J. W. Hirshfeld Jr, A. K. Jacobs, M. J. Kern, S. B. King III, D. A. Morrison, W. W. O'Neill, H. V. Schaff, P. L. Whitlow, et al. ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention--Summary Article: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention) Circulation, January 3, 2006; 113(1): 156 - 175. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Herrmann Peri-procedural myocardial injury: 2005 update Eur. Heart J., December 1, 2005; 26(23): 2493 - 2519. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P Bahrmann, H R Figulla, M Wagner, M Ferrari, A Voss, and G S Werner Detection of coronary microembolisation by Doppler ultrasound during percutaneous coronary interventions Heart, September 1, 2005; 91(9): 1186 - 1192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. L. Bhatt and E. J. Topol Periprocedural Cardiac Enzyme Elevation Predicts Adverse Outcomes Circulation, August 9, 2005; 112(6): 906 - 922. [Full Text] [PDF]
|
|
|
|
|
|
D. E. Cutlip and R. E. Kuntz Cardiac Enzyme Elevation After Successful Percutaneous Coronary Intervention Is Not an Independent Predictor of Adverse Outcomes Circulation, August 9, 2005; 112(6): 916 - 923. [Full Text] [PDF]
|
|
|
|
|
|
C. Cavallini, S. Savonitto, R. Violini, G. Arraiz, M. Plebani, Z. Olivari, P. Rubartelli, S. Battaglia, L. Niccoli, G. Steffenino, et al. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study Eur. Heart J., August 1, 2005; 26(15): 1494 - 1498. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W.-H. Chen, P.-Y. Lee, W. Ng, H.-F. Tse, and C.-P. Lau Is aspirin resistance or female gender associated with a high incidence of myonecrosis after nonurgent percutaneous coronary intervention? Reply J. Am. Coll. Cardiol., February 15, 2005; 45(4): 636 - 636. [Full Text] [PDF]
|
|
|
|
|
|
T. Palmerini, B. S. Coller, V. Cervi, L. Tomasi, A. Marzocchi, C. Marrozzini, O. Leone, M. Piccioli, and A. Branzi Monocyte-derived tissue factor contributes to stent thrombosis in an in vitro system J. Am. Coll. Cardiol., October 19, 2004; 44(8): 1570 - 1577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Briguori, A. Colombo, F. Airoldi, A. Violante, A. Focaccio, P. Balestrieri, P. Paolo Elia, B. Golia, S. Lepore, G. Riviezzo, et al. Statin administration before percutaneous coronary intervention: impact on periprocedural myocardial infarction Eur. Heart J., October 2, 2004; 25(20): 1822 - 1828. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Jeremias, D. S. Baim, K. K.L. Ho, M. Chauhan, J. P. Carrozza Jr, D. J. Cohen, J. J. Popma, R. E. Kuntz, and D. E. Cutlip Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures J. Am. Coll. Cardiol., September 15, 2004; 44(6): 1210 - 1214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Angelini, P. Rubartelli, F. Mistrorigo, M. Della Barbera, F. Abbadessa, M. Vischi, G. Thiene, and S. Chierchia Distal Protection With a Filter Device During Coronary Stenting in Patients With Stable and Unstable Angina Circulation, August 3, 2004; 110(5): 515 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.T. Roe, K.W. Mahaffey, R. Kilaru, J.H. Alexander, K.M. Akkerhuis, M.L. Simoons, R.A. Harrington, B.E. Tardiff, C.B. Granger, E.M. Ohman, et al. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes Eur. Heart J., February 2, 2004; 25(4): 313 - 321. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Iakovou, G. S. Mintz, G. Dangas, A. Abizaid, R. Mehran, Y. Kobayashi, A. J. Lansky, E. D. Aymong, E. Nikolsky, G. W. Stone, et al. Increased CK-MB release is a "trade-off" for optimal stent implantation: an intravascular ultrasound study J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1900 - 1905. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. O. Williams A twist in our understanding of enzyme elevation after coronary intervention J. Am. Coll. Cardiol., December 3, 2003; 42(11): 1906 - 1908. [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stone, D. A. Cox, J. Babb, D. Nukta, L. Bilodeau, L. Cannon, T. D. Stuckey, J. Hermiller, E. A. Cohen, R. Low, et al. Prospective, randomized evaluation of thrombectomy prior to percutaneous intervention in diseased saphenous vein grafts and thrombus-containing coronary arteries J. Am. Coll. Cardiol., December 3, 2003; 42(11): 2007 - 2013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. P. A. Ioannidis, E. Karvouni, and D. G. Katritsis Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention J. Am. Coll. Cardiol., October 15, 2003; 42(8): 1406 - 1411. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Henderson, S. J. Pocock, T. C. Clayton, R. Knight, K. A. A. Fox, D. G. Julian, D. A. Chamberlain, and Second Randomized Intervention Treatment of Angina Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy J. Am. Coll. Cardiol., October 1, 2003; 42(7): 1161 - 1170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Rukshin, R. Santos, M. Gheorghiu, P. K. Shah, S. Kar, S. Padmanabhan, B. Azarbal, V. T. Tsang, R. Makkar, B. Samuels, et al. A Prospective, Nonrandomized, Open-Labeled Pilot Study Investigating the Use of Magnesium in Patients Undergoing Nonacute Percutaneous Coronary Intervention with Stent Implantation Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2003; 8(3): 193 - 200. [Abstract] [PDF]
|
|
|
|
 |
|
 G. N. Levine, M. J. Kern, P. B. Berger, D. L. Brown, L. W. Klein, D. J. Kereiakes, T. A. Sanborn, A. K. Jacobs, and for the American Heart Association Diagnostic and Management of Patients Undergoing Percutaneous Coronary Revascularization Ann Intern Med, July 15, 2003; 139(2): 123 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Kizer, M. R. Muttrej, W. H. Matthai, J. McConnell, H. Nardone, A. F. Sonel, M. G. Keane, and R. L. Wilensky Role of cardiac troponin T in the long-term risk stratification of patients undergoing percutaneous coronary intervention Eur. Heart J., July 2, 2003; 24(14): 1314 - 1322. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P Marso, B. D Bliven, J. A House, G. F Muehlebach, and A.M. Borkon Myonecrosis following isolated coronary artery bypass grafting is common and associated with an increased risk of long-term mortality Eur. Heart J., July 2, 2003; 24(14): 1323 - 1328. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. A. Lemos, C.-h. Lee, M. Degertekin, F. Saia, K. Tanabe, C. A. Arampatzis, A. Hoye, M. van Duuren, G. Sianos, P. C. Smits, et al. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes: Insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry J. Am. Coll. Cardiol., June 4, 2003; 41(11): 2093 - 2099. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. G. Ellis, D. Chew, A. Chan, P. L. Whitlow, J. P. Schneider, and E. J. Topol Death Following Creatine Kinase-MB Elevation After Coronary Intervention: Identification of an Early Risk Period: Importance of Creatine Kinase-MB Level, Completeness of Revascularization, Ventricular Function, and Probable Benefit of Statin Therapy Circulation, September 3, 2002; 106(10): 1205 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Cantor, L. K. Newby, R. H. Christenson, R. H. Tuttle, V. Hasselblad, P. W. Armstrong, D. J. Moliterno, R. M. Califf, E. J. Topol, E. M. Ohman, et al. Prognostic significance of elevated troponin i after percutaneous coronary intervention J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1738 - 1744. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Colombo and G. Stankovic Nothing is lower than 0, and 3 is closer to 0 than to 5--medicine is not arithmetic Eur. Heart J., June 1, 2002; 23(11): 840 - 842. [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stone, D. J. Moliterno, M. Bertrand, F.-J. Neumann, H. C. Herrmann, E. R. Powers, C. L. Grines, J. W. Moses, D. J. Cohen, E. A. Cohen, et al. Impact of Clinical Syndrome Acuity on the Differential Response to 2 Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Coronary Stenting: The TARGET Trial* Circulation, May 21, 2002; 105(20): 2347 - 2354. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Nageh, R. A. Sherwood, and M. R. Thomas Prognostic Implications of Cardiac Marker Elevation After Percutaneous Coronary Intervention Circulation, March 26, 2002; 105 (12): e73 - e73. [Full Text] [PDF]
|
|
|
|
 |
|
 D. P. de Arenaza, A. Bakhai, M. Flather, P. Campbell, R. E. Gilbert, C. P. Cannon, and E. Braunwald Comparison of Early Invasive and Conservative Strategies in Patients with Unstable Coronary Syndromes N. Engl. J. Med., November 22, 2001; 345(21): 1573 - 1575. [Full Text] [PDF]
|
|
|
|
 |
|
 Type of MI After PCI Affects Survival Journal Watch Cardiology, October 26, 2001; 2001(1026): 11 - 11. [Full Text]
|
|
|
|
|
|
D. R. Holmes Jr and P. B. Berger Troponisms, Necrosettes, Enzyme Leaks, Creatinine Phosphokinase Bumps, and Infarctlets: What's Behind This New Lexicon and What Does It Add? Circulation, August 7, 2001; 104(6): 627 - 629. [Full Text] [PDF]
|
|